Surgical Management of Oropharyngeal Cancers Kerry D. Olsen, M.D. Professor, Otolaryngology Head and Neck Surgery Mayo Clinic Kerry D. Olsen, M.D. Professor,

Slides:

Advertisements

Similar presentations

Progress Against Stomach Cancer. 1980–1989 Progress Against Stomach Cancer 1980– : Combination chemotherapy improves outcomes for advanced stomach.

Advertisements

Progress Against Head and Neck Cancer. 1970–1979.

Neoadjuvant Chemotherapy in Locally Advanced Squamous Cell Cancer of Head and Neck Mei Tang, MD.

Multimodality Therapy of Rectal Cancer Robert D. Madoff, MD University of Minnesota.

Clinical Management of Head and Neck Cancer

Nasal cavity, paranasal sinuses, orbita and anterior skull base Moderator: Jeffrey Myers MD PhD Professor and Deputy Chair for Research Department of Head.

Neck Cancer Head and STATEMENTS ON January 28, 2006 Frankfurt am Main, Germany Surgery Surgery in Multimodal Treatment.

Age as a prognostic factor for head and neck squamous cell carcinoma: should older patients be treated differently? Udi Cinamon 1, Michael P. Hier 2, Martin.

Advanced squamous cell carcinoma of the bladder, What is next? Saleh A. Binsaleh.

H. AlHussain, I. Busca, L. Eapen,, S. El-Sayed The Ottawa Hospital Cancer Center, University of Ottawa Department of Radiation Oncology.

Controversies in Adjuvant Therapy for Pancreatic Cancer Parag Sanghvi M.D. Tasha McDonald M.D. Department of Radiation Medicine OHSU.

Joint Hospital Surgical Grand Round KL FOK NDH/AHNH Department of Surgery.

Indications for adjuvant radiation therapy with or without lymph nodes in salivary gland cancer Claus Rödel Department of Radiation Therapy University.

Postoperative Radiation for Oral Cavity Squamous Cell Carcinoma: The EP.

Radiofrequency Ablation of Lung Cancer

Synovial sarcoma- which patients don’t need adjuvant treatment? Khan M, Rankin KS, Beckingsale TB, Todd R, Gerrand CH North of England Bone and Soft Tissue.

Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.

Mauricio A. Moreno, M.D. Assistant Professor Department of Otolaryngology- Head and Neck Surgery University or Arkansas for Medical Sciences Mauricio A.

Carcinoma Oropharynx.

A Phase II Study to Evaluate the Safety and Toxicity of Sparing Radiation to the Pathologic N0 Side of the Neck in Squamous Cell.

National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.

THE LONG-TERM QUALITY OF LIFE OF HEAD AND NECK CANCER PATIENTS Gerry F. Funk, MD Department of Otolaryngology- Head and Neck Surgery University of Iowa.

Neck Cancer Head and STATEMENTS ON January 28, 2006 Frankfurt am Main, Germany Surgery Management of Lymph Node Metastases.

ACRIN 6685 Overview ACRIN 6685 A Multi-center Trial of FDG-PET/CT Staging of Head and Neck Cancer and its Impact on the N0 Neck Surgical Treatment in Head.

Definitive radiotherapy for head and neck cancer: the use of physical exam versus computed tomography to manage the post-RT neck Stanley Liauw*, Robert.

Recent Advances in Head and Neck Cancer Robert I. Haddad, M.D., and Dong M. Shin, M.D. The NEW ENGLAND JOURNAL of MEDICINE N Engl J Med 2008;359:

Anal Cancer - Case 1  62 years old woman with 6 months history of anal pain  Clinically T 3 squamous cell carcinoma growing anteriorly  Which staging.

Fred G. Fedok, MD FACS Facial Plastic and Reconstructive Surgery Otolaryngology / Head and Neck Surgery The Pharynx.

General principles for treatment selection Jeffrey Myers MD PhD.

Heat Shock Protein 90 (HSP90) is over-expressed in p16 negative oropharyngeal squamous cell carcinoma and its inhibition in vitro potentiates the effects.

Intensity-Modulated Radiotherapy is Associated with Improved Global Quality of Life Among Long-Term Survivors of Head and Neck Cancer Allen M. Chen, M.D.,

Simon K. Cheng 1, Kevin Stephenson 2, Lynn Shi 2, Kunal Chaudhary 1, Anshu Jain 1, David P. Horowitz 1, Sherry X. Yan 2, Tony Wang 1, Clifford Chao 1,

Carcinoma of the larynx

J. Lujan, G. Valero, Q. Hernandez, A. Sanchez, M.D. Frutos and P. Parrilla. British Journal of Surgery, September 2009.

1. Clinical Impression? Differentials?. Thyroid Carcinoma commonly manifests as a painless, palpable, solitary thyroid nodule The patient's age at presentation.

GASTRIC CANCER JHH Johns Hopkins Hospital Gastric Cancer , All Cases n=317 Analytic - Initially Diagnosed and/or received all or.

Quality of Life (QOL) & Patient Reported Outcomes (PRO) Lori Minasian, MD Chief, Community Oncology and Prevention Trials Research Group, DCP, NCI, NIH,

Radical surgery is the preferable treatment option for T1- 2/N0 low rectal cancer Jose G. Guillem, MD, MPH Department of Surgery Memorial Sloan Kettering.

HEAD/NECK CARCINOMA Johns Hopkins Hospital.

Journal Club Dr. Eyad Al-Saeed Radiation Oncology 12 January, 2008.

Duel Acquisition Neck CTA/ CT for Pre-TLM H&N Ca Patient Evaluation Steven M. Weindling, M.D. Mayo Clinic Florida XIX Symposium.

Cancer of the Head and Neck and HPV Infection Andrew Urquhart MD, FACS Dept. Otolaryngology/Head and Neck Surgery Marshfield Clinic.

Head & Neck Ca. (Epithelial tumors) Mohamad KADRI. MD. Clinical oncology. Medical director of AlBerouni University Hospital President of Syrian Association.

Beverlyn Jackson, MSN, RN, CCRN Nursing Faculty.  Upper respiratory cancers can include the following: bones - mandible, pharynx, oral mucosa, tonsils,

Date of download: 5/31/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Outcome of Salvage Total Laryngectomy Following Organ.

Professor Guram Karazanashvili MD, KMSc, DMSc MMT Hospital.

Robotic Surgery. Types of Surgery Cardiothoracic Surgery Cardiothoracic Surgery Colorectal Surgery ORL, Head & Neck Robotic Surgery Gynaecological Surgery.

Omega Best Cancer Hospital - India

Summary of staging criteria for cancers of the oral cavity, oropharynx, hypopharynx, and larynx. Carcinoma in situ is stage 0, and presence of distant.

Karcinom rektuma- management

Bone-anchored Mucosal Flap

Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.

OPTIMIZING TREATMENT FOR ADVANCED OVARIAN CANCER:

Oral cancer in india Oral cancer ranks in the top three of all cancers in India, which accounts for over thirty per cent of all cancers reported in.

Cancer of the Head and Neck and HPV Infection

Shanthi Marur, MD, Arlene A. Forastiere, MD Mayo Clinic Proceedings

TNM 8 UPDATE Head and Neck SSG March 2018

Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival Elizabeth A. David, MD, Robert J. Canter,

Surgery vs. primary radiotherapy in early-stage oropharyngeal cancer

Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer Akihito Watanabe, MD, Masao Hosokawa, MD,

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial Stacey.

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Thymoma: A Population-Based Study of the Management and Outcomes for the Province of British Columbia Caroline Mariano, MD, Diana N. Ionescu, MD, Winson.

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Management of Prostate Cancer: Global Strategies

Prognosis of angiosarcoma at different anatomic sites

Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia Jacob J. Inda, MD, Brian F. Kabat,

A–J, Pretreatment (A) and post–cycle 3 (B) computed tomographic imaging for patient A–J, Pretreatment (A) and post–cycle 3 (B) computed tomographic.

Presentation transcript:

Surgical Management of Oropharyngeal Cancers Kerry D. Olsen, M.D. Professor, Otolaryngology Head and Neck Surgery Mayo Clinic Kerry D. Olsen, M.D. Professor, Otolaryngology Head and Neck Surgery Mayo Clinic Surgical Management of Oropharyngeal Cancers Frankfurt – January 2008

Advanced Oropharyngeal Cancer  Organ preservation philosophy: Surgical Management of Oropharyngeal Cancers Frankfurt – January 2008 What is the functional benefit of preserving the tonsil or half of the tongue base?

The National Cancer Data Base Report on Squamous Cell Carcinoma of the Base of Tongue Head and Neck May 2004  Largest contemporary overview of presentation cure and outcome for base of tongue SCC  16,188 cases75%Stage 3, 4 ( )  Treatment%Patients Surgery16 2,561 Radiation24 3,972 Surgery + Rad27 4,354 Rad + Chemo14 2,342 Surgical Management of Oropharyngeal Cancers Frankfurt – January 2008

 Outcome: Early stage 1, 2 disease 5-year Disease Specific Survival Surgery75% Radiation46% Rad + Chemo29% Advanced stage 3, 4 disease 5-year Disease Specific Survival Surgery + Rad51% Surgery42% Rad + Chemo26% Rad24% Surgical Management of Oropharyngeal Cancers Frankfurt – January 2008

Tongue Base Squamous Cell Carcinoma  219 patients – advanced stage 3, 4 All completed treatment Disease specific survival 5 yr Surgery 83% Surgery/RT 60% Chemo/RT 23% Kowalski, L. M.D.  219 patients – advanced stage 3, 4 All completed treatment Disease specific survival 5 yr Surgery 83% Surgery/RT 60% Chemo/RT 23% Kowalski, L. M.D. Surgical Management of Oropharyngeal Cancers Frankfurt – January 2008

Oropharyngeal Cancer  Prevailing opinion: Surgery Difficult to approach Extensive time commitment Poor reimbursement Won’t eat Leak Send for alternative therapy Reality Good function in vast majority Short hospitalization Surgical Management of Oropharyngeal Cancers Frankfurt – January 2008

Oropharyngeal Cancer Surgical Management  In reality, most cases: Don’t exhibit bone invasion (mandible) Don’t involve the larynx to a significant degree Spare one or both hypoglossal nerves Don’t involve majority of the soft palate Don’t involve carotid artery, para- pharyngeal space/pre-vertebral fascia Are accessible surgically Surgical Management of Oropharyngeal Cancers Frankfurt – January 2008

102 Patients Tonsil Cancer Transoral Excision  Mayo Clinic1996 – 2004  84%Stage 3, 4  25% S70% S+R5% S+R+C  5 yrL – R – D free recurrence 92% - 97% - 91%  Overall survival: 2 yr92% 5 yr85% Surgical Management of Oropharyngeal Cancers Frankfurt – January 2008

Surgical Management Oropharyngeal Cancer  No functional benefit to preserve tonsil or ½ tongue base  National Cancer Data Base 2004 S 2,561 pts R 3,972 pts S+R 4,354 pts R+C 2,342 pts Stage 1, 2 S 75% R 40% R+C 29% Stage 3, 4 S+R 51% S 42% R+C 26% R 24% Five year disease specific survival  Stage 3, 4 tongue base cancer – 219 patients by Kowalski Disease specific survival 5 yr S 83% S+R 60% R+C 23%  Tonsil Cancer – 102 patients Mayo Clinic 84% Stage 3, 4 5 yr L – R – D free recurrence 92% - 97% - 91% Overall survival2 yr 92% 5 yr 85% Surgical Management of Oropharyngeal Cancers Frankfurt – January 2008

Surgical Management of Oropharyngeal Cancers Frankfurt – January 2008

Surgical Management of Oropharyngeal Cancers Frankfurt – January 2008